Pasha Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 9 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth %
- Profit Growth -973.88%
- Ebitda -2136.97%
- Net Worth -580.97%
- Total Assets 467.09%
About Pasha Biotech
Pasha Biotech Private Limited (PBPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 December 2015 (Nine years and two months 2 days old ). Its registered office is in West Delhi, Delhi, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Pramod Sethi and Manish Kumar serve as directors at the Company.
Company Details
-
Location
West Delhi, Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999DL2015PTC288333
-
Company No.
288333
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
10 Dec 2015
-
Date of AGM
28 Aug 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Pasha Biotech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pramod Sethi
|
Director | 10-Dec-2015 | Current |
Manish Kumar
|
Director | 10-Dec-2015 | Current |
Financial Performance of Pasha Biotech.
Pasha Biotech Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 973.88% decrease in profit. The company's net worth observed a substantial decline by a decrease of 580.97%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pasha Biotech?
Unlock access to Pasha Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Rope Pharma Private LimitedPramod Sethi and Manish Kumar are mutual person
-
Manpra Pharm Private Limited
Pramod Sethi and Manish Kumar are mutual person
-
Save Earth Labs Private Limited
Pramod Sethi and Manish Kumar are mutual person
-
God Gift Laboratory Private Limited
Pramod Sethi and Manish Kumar are mutual person
-
Miller Pharm Private Limited
Pramod Sethi and Manish Kumar are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Pasha Biotech?
Unlock and access historical data on people associated with Pasha Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pasha Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pasha Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
